SYS | | c032027 |
LBL | | ^^^^^nam^^22^^^^^^^^450^ |
005 | | 20130408173322.4 |
100 | | $a 20050607d2005 m y0sloc0103 ba |
101 | 0- | $a eng |
102 | | $a GB |
105 | | $a a orz 100yy |
200 | 1- | $a Masterclass in nephrology $d Antibody-mediated pure red cell aplasia-lessons and challenges in the treatment of anaemia $e 24-25th September 2004. Cannes, France $f guest ed. Jérôme Rossert |
210 | | $a Oxford, U.K. $c Oxford University Press $d 2005 |
215 | | $a iv36 s. $c il., obr., grafy, tab. |
225 | 2- | $a Nephrology, Dialysis, Transplantation $v suppl. 4 $x 0931-0509 |
320 | | $a Obsahuje bibliografické odkazy |
510 | 1- | $a Antibody-mediated pure red cell aplasia-lessons and challenges in the treatment of anaemia |
541 | 1- | $a Majstrovské prednášky z nefrológie $e Prednášky zaoberajúce sa protilátkami sprostredkovanou čistou apláziou erytrocytov a novými výzvami v terapii anémie. 24.-25. september 2004, Cannes, Francúzsko |
606 | 1- | $a aplázia erytrocytov, čistá $x etiológia $x imunológia $x epidemiológia $2 mesh $3 sllk_un_auth*d012010 $9 . |
606 | 1- | $a aplázia erytrocytov, čistá $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d012010 $9 . |
606 | 2- | $a erytropoetín $2 mesh $3 sllk_un_auth*d004921 $9 . |
606 | 2- | $a protilátky $2 mesh $3 sllk_un_auth*d000906 $9 . |
606 | 2- | $3 sllk_un_auth*d004921 $a erytropoetín $9 . $2 mesh |
606 | 2- | $a ekvivalencia terapeutická $2 mesh $3 sllk_un_auth*d013810 $9 . |
606 | 2- | $a generiká $2 mesh $3 sllk_un_auth*d016568 $9 . |
608 | | $3 sllk_un_auth*d016423 $a kongres $2 mesh |
675 | | $a 616.61-008.64-06:616.155.195-05-095(063) $v 2. $z slo |
702 | -1 | $a Rossert $b Jérôme $3 sllk_un_auth*p0041974 $4 340 |
712 | 02 | $3 sllk_un_auth*k0000003 $a European Renal Association $4 070 |
712 | 02 | $3 sllk_un_auth*k0000004 $a European Dialysis and Transplant Association $4 070 |
712 | 12 | $a Masterclass in nephrology $c Antibody-mediated pure red cell aplasia-lessons and challenges in the treatment of anaemia $e Cannes, Francúzsko $f 2004 $3 sllk_un_auth*k0003191 $4 070 |
801 | -0 | $a SK $b BA006 $c 20050607 $g AACR2 |